Efficacy and safety of direct oral anticoagulants in pediatric patients: a systematic review and meta-analysis
Frontiers in Public Health · 07.04.2026 · 14
DOI: 10.3389/fpubh.2026.1787819 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Public Health, online erschienen am 07.04.2026. Verfasst von Siyi You und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Anticoagulants, Thromboembolism. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Thromboembolic events (TE) are increasingly recognized in pediatric patients, necessitating optimal antithrombotic therapy. While direct oral anticoagulants (DOACs) offer potential advantages over standard of care (SOC) such as heparin, comprehensive evidence regarding their use for treatment and prophylaxis remains limited. Therefore, we performed a systematic review and meta-analysis to assess the efficacy and safety of these two classes of anticoagulants.
Methods
We searched PubMed, Embase, Web of Science, and ClinicalTrials.gov up to November 27, 2025, for relevant randomized controlled trials (RCTs) comparing DOACs with SOC in pediatric patients. Data were synthesized using fixed- or random-effects models to calculate risk ratios (RRs) with 95% confidence intervals (CIs).
Results
Eight RCTs involving 2,002 pediatric patients were included. In terms of efficacy, DOACs were associated with a significant reduction in TE recurrence in treatment studies ( RR = 0.50; 95% CI 0.25–0.99) and TE occurrence in prophylaxis studies ( RR = 0.63; 95% CI 0.42–0.95). Regarding safety, major bleeding was comparable to SOC with a favorable trend observed for DOACs ( RR = 0.64; 95% CI 0.26–1.55). No significant differences were found in all-cause mortality and serious adverse events.
Conclusion
DOACs represent an effective alternative to SOC for the treatment and prevention of thromboembolism in children, demonstrating superior efficacy without increasing the risk of bleeding events.
Systematic review registration
PROSPERO https://www.crd.york.ac.uk/PROSPERO/view/CRD42024506541 , CRD42024506541.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
- Department of Ultrasonography, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
You, S., Gan, Y., Sun, X., Tang, Y., Ying, J., & Mu, D. (2026). Efficacy and safety of direct oral anticoagulants in pediatric patients: a systematic review and meta-analysis. Frontiers in Public Health, 14. https://doi.org/10.3389/fpubh.2026.1787819
Vancouver
You S, Gan Y, Sun X, Tang Y, Ying J, Mu D. Efficacy and safety of direct oral anticoagulants in pediatric patients: a systematic review and meta-analysis. Frontiers in Public Health. 2026;14. doi:10.3389/fpubh.2026.1787819
BibTeX
@article{You2026,
author = {You, Siyi and Gan, Yan and Sun, Xuemei and Tang, Ying and Ying, Junjie and Mu, Dezhi},
title = {Efficacy and safety of direct oral anticoagulants in pediatric patients: a systematic review and meta-analysis},
journal = {Frontiers in Public Health},
year = {2026},
volume = {14},
doi = {10.3389/fpubh.2026.1787819}
}
EUVIMED